THE ARISING · Longevity & Healthspan
Probiotics Linked to Better Cognitive Test Scores in Mild Impairment and Alzheimer's, Meta-Analysis Finds
Across ten randomized trials, people with mild cognitive impairment or Alzheimer's disease who took probiotics or synbiotics scored higher on thinking tests than those given placebo or usual care. The authors rated the evidence very low certainty.
The finding comes from a systematic review and meta-analysis published in Ageing Research Reviews in 2026 by Zhang M, Zhang H, Fu B and Xu D. A meta-analysis pools results from several earlier studies into one estimate. This one combined ten randomized controlled trials with 739 participants in total.
The authors searched four databases: PubMed, Embase, Web of Science and the Cochrane Library. They included trials that compared live probiotics or synbiotics with placebo or usual care. A synbiotic pairs a probiotic with a prebiotic, a food source for gut microbes. The participants had mild cognitive impairment, Alzheimer's disease or related cognitive decline.
Because trials use different cognitive tests, the team expressed each result as a standardized mean difference. This puts all the scores on a common scale. The pooled difference was 0.50, with a 95% confidence interval of 0.19 to 0.81, in favor of probiotics or synbiotics. The authors describe this as a possible improvement in cognitive function.
The trials did not agree closely. The authors report substantial variation between them (I² of 76%). The authors rate the certainty of the evidence as very low, and the range expected for a future setting, from -0.57 to 1.57, includes no benefit at all.
For anyone wondering which product might matter, the analysis offers no clear answer. The authors found no statistically significant differences in effect by disease category, length of treatment, type of intervention, average age of participants, strain mix, dose or the cognitive test used. Sensitivity analyses kept the direction and statistical significance of the pooled effect. A test for small-study effects, which can distort pooled results, did not detect significant small-study effects (P = 0.318).
The authors conclude that probiotics or synbiotics may improve cognitive test performance. They also call for larger, well-designed randomized trials.
Next to watch is whether larger trials with consistent methods show that the test-score gain holds up, and for whom.